Tyratech (DI) Share Discussion Threads

[haroldthegreat] 22/8/2017 12:29

How can she remember who they came in contact with 10 weeks previously. At least she sensibly purchased 2 csns a head. my point is how many English families would go and fork out £180 on the purchase without asking is there anything cheaper. No doubt the American sales will help produce bumper sales and make this a brilliant investment for michael and make all his pumping worthwhile. The chart says otherwise.michael why don't you contact her to help you in your takeover bid for this massively underpriced company.

[michaelsadvfn] 22/8/2017 11:26

16 cans for one family....

PLEASE BUY THIS!!! IT WORKS!! 8/10/2016
Customer review by MOM6
5.0 stars by MOM6
I have 6 kids and one of them got the infestation from a member in church. From one head to another until all 6 kids plus me and my husband got them. I struggled for 4 years trying to get rid of the lice and there eggs i used everything there was on the market that i knew about. I even paid 1000 dollars to get them professionally done for all of us which is 8 people in total did all the visits kept up with instructions on boxes washed all the sheets placed all the stuffed animals in bags etc... NOTHING worked!!! Finally I saw this product Vamousse and said i might as well try something different even tho i felt as mouse would not be sufficient enough to kill eggs and lice but I gave it a shot. I bought so many boxes 2 per head only because we all have extremely thick and long hair. I followed the steps and guess what it worked I didn't even have to apply it a second time. Please take it from a mom that has 6 kids lost days of work and kids missed school for the biggest headache of Lice.. Buy this product it WORKS!!

[nobbygnome] 22/8/2017 10:57

Yes very interesting. Most population centres are medium or medium high!

Bad for the population but good for TYR!

Nobby

[michaelsadvfn] 22/8/2017 10:43

Food for thought...



No numbers but last year's downturn looks like it may have reversed.

[michaelsadvfn] 18/8/2017 08:10

harry,

I've just emailed Bruno with a suggestion he includes the following advice on the Vamousse packaging...

Not suitable for 2-year-old, pregnant, breast-feeding asthmatics with a skin condition.

Hope that helps.

[haroldthegreat] 17/8/2017 20:00

Sorry you can't read the nice report. No doubt others can and will.just carry on pumping. I am also sorry the mcap is greater than that quoted on ADVFN and so out of reach for you to make a takeover bid .
any news on the household powder being sold in France ? Is this going to get the share price back to 10p ?

[michaelsadvfn] 17/8/2017 19:36

As they say turnover is vanity profit is sanity...

In 2016 Vamousse made a net profit of $2.2m on $8m worth of sales.

If the market cap is wrong why not get ADVFN to correct it...

I'm not going to spell it out again and it's not my job to alter the ADVFN software to take into consideration there are 2 lines of stock.

If they have 8% of the us market surely the price would have risen...

That's a very naive comment coming from a self proclaimed 'intelligent professional'.
As mudbath would say, sentiment can turn on a sixpence. It turned on a sixpence when the share price rose from 4.5p to 22p yet nothing about the company had changed, in fact at the time they had no sales whatsoever and the market cap reached almost £40m so don't assume there's any logic in the market. There isn't.

I can't access the report as it is only available to U.K. residents.

I won't comment on the rest of your input, save to say the product works and people are buying it.

[haroldthegreat] 17/8/2017 18:56

You might like to read nice report hxxps://cks.nice.org.uk/head-lice#!scenario.
especially
Isopropyl myristate and isopropyl alcohol (Vamousse®, registered medical device)
Advantages
Largely physical action, so resistance is unlikely to develop.
Disadvantages
There is a lack of safety data on its use in pregnant or breastfeeding women or children younger than 2 years of age. CKS recommends Hedrin® Lotion for use in these groups, as it is licensed for use in these groups [ABPI Medicines Compendium, 2014].
There is a lack of trial data for use by people with skin conditions.
Contains alcohol so not recommended for people with asthma.
There are no published clinical trials on its use.


Today the chemist and druggist has published an article on lice. Because of copyright I cannot reproduce it but it does bring up the cost of some products.

With these physical products its essential to apply sufficient product and if something is expensive patients will be mean with it and it will not work.

[haroldthegreat] 17/8/2017 18:44

As they say turnover is vanity profit is sanity. If the market cap is wrong why not get ADVFN to correct it. If you are convinced the share is such a good buy make a takeover bid. If they have 8% of the us market surely the price would have risen rather than. It would appear you are the only person in the country that has noticed this anomaly. When the chart goes up like it's on viagra I will agree the 8% market share is profitable to the company.

[michaelsadvfn] 17/8/2017 15:30

michaelsadvfn 17 Aug '17 - 12:11 - 2076 of 2082 0 0 Edit

If Vamousse is too expensive how come it has grabbed 8% of the USA market?


haroldthegreat 17 Aug '17 - 12:22 - 2077 of 2082 0 0

Because the idiots in the states have been using pesticide products that lice develop resistance to.

So Tyratech saw an opportunity, offered an alternative and have taken 8% of the market.

How could management have been so stupid?

[haroldthegreat] 17/8/2017 12:55

What michael needs is help to get the price of this share up. Perhaps you might like to take a % of his takeover bid. I was just pointing out the prof would not help and it is obvious neither would I. Bruno could buy more shares.

[michaelsadvfn] 17/8/2017 12:47

harry,

I've already told you how to calculate the market cap., which isn't £1.63m.

Do pay attention.

U.K. sales were up 27% last year so people ARE prepared to pay a bit more for a natural product that actually works first time. Perhaps you're just not doing your job properly if you can't attract buyers of Vamousse; everyone else can.

Upcoming results will tell us exactly how they're doing.

[haroldthegreat] 17/8/2017 12:37

In fact over the years in the UK the mousse formats have been least popular in the UK.

[mudbath] 17/8/2017 12:31

michaelsadvfn
Thanks for the link.
The Euromonitor Research Study conclusion was particularly relevant.

"While shampoo is still the predominant product format for LCP, newer formats like
sprays and mousses grew the fastest during the historic period (2012-2016). Consumers
are willing to try newer product formats after experiencing shampoo LCPs that didn’t
solve the problem. However, it is important to note that shampoos are expected to
continue to dominate product formats through 2021 because consumers most associate
shampoo with LCP treatments."

[chinese investor] 17/8/2017 12:24

harold,
The Prof NEEDS help.

[haroldthegreat] 17/8/2017 12:22

Because the idiots in the states have been using pesticide products that lice develop resistance to. We intelligent UK medical professionals stopped using them years ago.in the UK however we are not prepared to pay £15 a can x 4 to treat 4 hairy lousy people. The. share price chart says it all despite your perpetual pumping.with a bargain? Mcap of 1.63 million why don't you buy the company.? You could put your optimistic ideas to a lender who would no doubt lend you the funds to do it. Perhaps nobby would buy half to help you out. I do not think the Prof would be willing to help.

[michaelsadvfn] 17/8/2017 12:11

Some info for harry...



Widespread concern about pesticide-resistant “super lice” has boosted growth in pesticide-free products. Products with the pesticide-free claim command the highest retail prices, as observed in store audits.

If Vamousse is too expensive how come it has grabbed 8% of the USA market?

Just wondering like.

[michaelsadvfn] 14/8/2017 09:02

We're going nowhere without news.

If U.S. infestations are back to normal levels we could be in for quite a good first half. Growth is key if they are looking to attract partners/investment. Fingers xxd.

[chinese investor] 14/8/2017 08:07

Here We Go !

[michaelsadvfn] 10/8/2017 20:50

Pathological Pettigrew will agree with you, no doubt about that, but I would wait until
we hear more regarding the ongoing review before suggesting there will be substantial dilution. Neither you nor I have any idea what's on the cards.

They might sell Vamousse(which I doubt), they might find a partner with deep pockets to take Vamousse forward(most likely). Neither of those options suggest there will be any dilution, in fact both would be seen as positive by the market.

We will know more by next month at the latest as the first half results will be published in September.

My money is on 2 partners taking stakes for providing funding, one for the AH side and one for the HH side.

[professor pettigrew] 10/8/2017 20:47

mudbath - you are either an optimist, or a complete idiot.

If you believe anything "michaels" says, you want your head testing.

[arthur_lame_stocks] 10/8/2017 19:23

I like this little company for the contribution that vamousse is making, but they almost certainly need fresh funds and with the price so low there will be substantial dilution.

Too early to invest IMO.

Arthur

[mudbath] 09/8/2017 15:22

Whilst I would prefer the share price to be higher,Tyratech retains my interest and investment.
As michaelsadvfn has said,lets wait for the updates for they will hopefully serve to generate some interesting discussion and potentially stimulate renewed buying.